Designed for easy, on-demand
access, the hub features expert-led presentations, slides, and videos covering
emerging agents and approaches in lung cancer, including immunotherapy,
targeted therapy, antibody-drug conjugates, bispecific agents, and monitoring
for minimal residual disease. Whether you attended the meeting or are catching
up, this free resource offers a convenient way to revisit insights and apply
the latest developments to your clinical practice—all in 1 place.
This activity is supported by educational grants from AbbVie,
Inc; AstraZeneca Pharmaceuticals; Exact Sciences Corporation; Merck & Co,
Inc; Nuvalent, Inc; Partner Therapeutics, Inc; and Revolution Medicines, Inc.
Browse and take individual modules below, or enroll in the full path to track your overall progress.

Slide Downloads
Slide Downloads